Covance, a global contract research organization, worked on all of the top 50 best-selling drugs available today through its full spectrum of nonclinical, clinical and commercialization services.
Covance is a top CRO company, dedicated to advancing healthcare and delivering Solutions Made Real®
With precision delivery of the largest volume of drug development data on the planet, we can help you identify new approaches and anticipate tomorrow’s challenges. Learn more about our history and services.
Join Covance Market Access: booth 401 at ISPOR Boston
Find out how we enable customers to optimize their clinical & commercial development programs
Proactive risk management for ICH E6 compliance
Understand the recent changes to the ICH E6 guideline. Leverage a three-tier strategy.
Exceptional people. Extraordinary paths.
Discover your potential with a company that truly invests in you.
Phase I cGMP Drug Manufacturing at the CRU | June 6 - 11:00 a.m. EDT
Register now to learn the three key benefits.
Immuno-oncology and the role of biomarkers, companion and complementary diagnostics
Learn more about how the use of a variety of biomarkers, companion diagnostics (CDx) and complementary diagnostics has powered the recent evolution of immunotherapies and their potential applications.
Increasing operational efficiency and transparency using clinical trial informatics
You know Covance as one of the most highly regarded CROs in the world. But did you know that Covance is also a clinical trial technology provider? Join us for a webinar on June 14 - 11 a.m. EDT. Register today.
Biomarkers and immuno-oncology: Identifying new opportunities for precision medicine | Watch the recording now
Register for the webinar today.
Meet us at DIA in Chicago – booth 627 | June 18-22 - Chicago, IL
Covance will be at DIA with patient centricity, patient recruitment and informatics subject matter experts on hand. Request a meeting with one of our subject matter experts or attend one of our informative sessions.
The diabetic heart: A focus on heart failure recording now available
Hear an insightful discussion on how certain molecular classes impact CV outcomes for patients with type 2 diabetes along with strategies for testing new therapeutic, paradigm-modifying treatment modalities.
Analytical methods for bioanalysis
Check out our recently updated nonproprietary assay list featuring more than 330 compounds.
Introducing biosimilar CMC analytical master files
Innovative & invaluable solutions for biosimilar development. Pre-developed, risk-mitigated biosimilarity assessment, testing solutions, data evaluation and consultation.
Multiple indications. A fundamental approach.
Experience with 14 of the 15 top IMID drugs. Over 470 IMID clinical trials in the past five years. A broad, well-coordinated platform of services
The biosimilars landscape: What all developers need to know recording now available
The regulatory pathway for developing biosimilars in the U.S. is still considered a new frontier. View this webinar as we discuss the key clinical issues sponsors face when navigating today’s regulatory environment.
Have you visited the NASH Education Center?
We’re pleased to announce the launch of the NASH Education Center. Access the latest thoughts from experts through webinars, case studies, blogs, info sheets and scientific articles.
Phase IIb/III Clinical Trials
Your approval. Our common goal.
As you move over to high stakes clinical development, you’ll benefit from an end-to-end suite of services, relentlessly focused on your drug’s approval.
Life Cycle Management
Maximize the value of your molecule through its life cycle.
Reaching the market isn’t the end of the road for your molecule. Covance Life Cycle Management (LCM) solutions ensure your molecule’s potential is fully realized.
Virtual Clinic Tour
Go inside our Madison Clinical Research Unit
On-campus radioanalysis means faster results and deep insights into drug metabolism. Learn more by touring our Madison CRU.